Alector, Inc. (ALEC) vs Anbio Biotechnology Class A Ordinary Shares (NNNN)

A side-by-side comparison of Alector, Inc. and Anbio Biotechnology Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alector, Inc. logo
ALEC
Alector, Inc.
$210M
$1.89HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
Anbio Biotechnology Class A Ordinary Shares logo
NNNN
Anbio Biotechnology Class A Ordinary Shares
$217M
$4.95HealthcareDelayed quote: Oct 6, 2026, 11:04 AM EDT

Total return — ALEC vs NNNN

growth of $100 · dividends reinvested · last 2y
ALEC +8.7% (+4.3%/yr)NNNN -16.3% (-8.5%/yr)ALEC compounded faster over this window
0200400600800Start $1002026$109$84
ALEC NNNN

ALEC vs NNNN: by the numbers

  • •NNNN is the larger company ($217M vs $210M market cap).
  • •NNNN is profitable (74.06% net margin) while ALEC runs a net loss (-850.13%).

Metrics side by side

Valuation

MetricALECNNNN
P/S ratio15.12N/A
P/B ratioN/A7.20

Profitability

MetricALECNNNN
Gross margin54.09%87.24%
Operating margin-692.83%66.70%
Net margin-850.13%74.06%
ROEN/A21.24%
ROIC-71.04%19.13%

Growth (annualized)

MetricALECNNNN
Revenue CAGR (5Y)-8.35%N/A
Total return CAGR (5Y)-39.17%N/A

Frequently asked

Is ALEC or NNNN more profitable?
NNNN runs the higher net margin — ALEC at -850.13% versus NNNN at 74.06%.

Go deeper

Full ALEC analysisFull NNNN analysisInteractive comparison tool

Dig into the metrics

Alector ROEAnbio Biotechnology Class A Ordinary Shares ROEAlector operating marginAnbio Biotechnology Class A Ordinary Shares operating marginAlector revenue growthAnbio Biotechnology Class A Ordinary Shares revenue growthAlector free cash flowAnbio Biotechnology Class A Ordinary Shares free cash flow

Alector & Anbio Biotechnology Class A Ordinary Shares appear in these rankings

Highest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.